Identiv (INVE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
26 Jun, 2026Executive summary
Strategic transaction announced to combine with Trackonomy, focusing on regulatory and compliance SaaS opportunities post-close.
The culmination of a two-year strategic review, with the board concluding this partnership offers the best value for shareholders.
Forward-looking statements highlight anticipated benefits, required approvals, and potential risks related to the transaction and future business model.
Voting matters and shareholder proposals
Shareholder approval is required for the transaction, with a proxy statement to be filed for solicitation.
A $40 million share buyback is planned as part of capital return to shareholders.
Board of directors and corporate governance
Directors and executive officers are participants in the proxy solicitation, with detailed information available in recent SEC filings.
The board and management have led an extensive review of strategic alternatives over two years.
Latest events from Identiv
- Shareholders are asked to approve the IoT business sale, executive pay, director elections, and auditor ratification.INVE
Proxy filing17 Jul 2026 - Identiv to sell IoT assets to Trackonomy, pivot to SaaS, and launch a $40M stock buyback.INVE
Proxy filing25 Jun 2026 - Identiv sells IoT assets to Trackonomy, pivots to SaaS and Physical AI, and secures $50M equity.INVE
M&A announcement24 Jun 2026 - Definitive IoT asset sale and SaaS partnership, with expanded governance and $40M buyback.INVE
Proxy filing24 Jun 2026 - Q1 revenue up 41%, margins improved, and major customer order boosted results.INVE
Q1 202614 May 2026 - Margins improved and losses narrowed in Q4/FY 2025, with new BLE supply deal and strong 2026 outlook.INVE
Q4 202512 Mar 2026 - Q2 revenue and margins fell as a $145M asset sale and IoT pivot advance toward Q3 closure.INVE
Q2 20242 Feb 2026 - Asset sale drove $99.5M gain, $145.4M cash, but core revenue and margins declined.INVE
Q3 202415 Jan 2026 - Revenue and margins fell, but transformation and strong cash reserves support future growth.INVE
Q4 202425 Dec 2025